Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Isidori, Alessandro
SELECT MDS-1, NCT04797780 / 2020-004528-40: Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome	Recruiting	3	550	Europe, Canada, US, RoW	Tamibarotene, SY-1425, Placebo, Azacitidine	Syros Pharmaceuticals	Myelodysplastic Syndromes	11/24	02/29
PV-ARC, NCT06134102: Clinical and Laboratory Characteristics of Polycythemia Vera	Completed	N/A	1150	Europe		IRCCS Azienda Ospedaliero-Universitaria di Bologna	Polycythemia Vera	12/23	12/23
RUX-MF, NCT06516406: Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera	Recruiting	N/A	1055	Europe		IRCCS Azienda Ospedaliero-Universitaria di Bologna	Myelofibrosis, Primary Myelofibrosis, Secondary Myelofibrosis	05/32	05/32
CML1012, NCT01752062: Observational Study of Conception/Pregnancy in Adult Patients With CML Treated With Tyrosine Kinase Inhibitors	Recruiting	N/A	148	Europe		Gruppo Italiano Malattie EMatologiche dell'Adulto	Chronic Myeloid Leukemia, Pregnancy	12/22	12/22

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Isidori, Alessandro
SELECT MDS-1, NCT04797780 / 2020-004528-40: Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome	Recruiting	3	550	Europe, Canada, US, RoW	Tamibarotene, SY-1425, Placebo, Azacitidine	Syros Pharmaceuticals	Myelodysplastic Syndromes	11/24	02/29
PV-ARC, NCT06134102: Clinical and Laboratory Characteristics of Polycythemia Vera	Completed	N/A	1150	Europe		IRCCS Azienda Ospedaliero-Universitaria di Bologna	Polycythemia Vera	12/23	12/23
RUX-MF, NCT06516406: Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera	Recruiting	N/A	1055	Europe		IRCCS Azienda Ospedaliero-Universitaria di Bologna	Myelofibrosis, Primary Myelofibrosis, Secondary Myelofibrosis	05/32	05/32
CML1012, NCT01752062: Observational Study of Conception/Pregnancy in Adult Patients With CML Treated With Tyrosine Kinase Inhibitors	Recruiting	N/A	148	Europe		Gruppo Italiano Malattie EMatologiche dell'Adulto	Chronic Myeloid Leukemia, Pregnancy	12/22	12/22